Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6005)
All Articles published online
|
Publishing Process of This Article
|
Sep 7, 2013 (publication date) through Dec 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Khare S, Zhang Q, Ibdah JA. Epigenetics of hepatocellular carcinoma: Role of microRNA. World J Gastroenterol 2013; 19(33): 5439-5445 [PMID: 24023486 DOI: 10.3748/wjg.v19.i33.5439] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i33/5439.htm |
| Number | Citing Articles |
| 1 |
Guangbin Jiang, Li Wen, Hongmei Zheng, Zhiyuan Jian, Weiping Deng. miR‐204‐5p targeting SIRT1 regulates hepatocellular carcinoma progression. Cell Biochemistry and Function 2016; 34(7): 505 doi: 10.1002/cbf.3223
|
| 2 |
Shixiong Ding, Airong Hu, Yaoren Hu, Jianbo Ma, Pengjian Weng, Jinhua Dai. Anti-hepatoma cells function of luteolin through inducing apoptosis and cell cycle arrest. Tumor Biology 2014; 35(4): 3053 doi: 10.1007/s13277-013-1396-5
|
| 3 |
Hepatoprotective Effect of Kaempferol: A Review of the Dietary Sources, Bioavailability, Mechanisms of Action, and Safety. Advances in Pharmacological and Pharmaceutical Sciences 2023; 2023: 1 doi: 10.1155/2023/1387665
|
| 4 |
Hyo Jung Cho, Soon Sun Kim, Ji Sun Nam, Jai Keun Kim, Jei Hee Lee, Bohyun Kim, Hee Jung Wang, Bong Wan Kim, Jung-Dong Lee, Dae Yong Kang, Ji Hyun Kim, Yang Min Jae, Jae Chul Hwang, Sung Jae Shin, Kee Myung Lee, Sung Won Cho, Jae Youn Cheong. Low levels of circulating microRNA-26a/29a as poor prognostic markers in patients with hepatocellular carcinoma who underwent curative treatment. Clinics and Research in Hepatology and Gastroenterology 2017; 41(2): 181 doi: 10.1016/j.clinre.2016.09.011
|
| 5 |
DAI SHIMIZU, MITSURO KANDA, SHUJI NOMOTO, HISAHARU OYA, HIDEKI TAKAMI, SOKI HIBINO, MASAYA SUENAGA, YOSHIKUNI INOKAWA, MITSUHIRO HISHIDA, NAO TAKANO, YOKO NISHIKAWA, SUGURU YAMADA, TSUTOMU FUJII, GORO NAKAYAMA, HIROYUKI SUGIMOTO, MASAHIKO KOIKE, MICHITAKA FUJIWARA, YASUHIRO KODERA. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma. Oncology Reports 2014; 31(3): 1305 doi: 10.3892/or.2013.2939
|
| 6 |
Peyda Korhan, Esra Erdal, Neşe Atabey. miR-181a-5p is downregulated in hepatocellular carcinoma and suppresses motility, invasion and branching-morphogenesis by directly targeting c-Met. Biochemical and Biophysical Research Communications 2014; 450(4): 1304 doi: 10.1016/j.bbrc.2014.06.142
|
| 7 |
JIN GONG, XING-XING HE, DE-AN TIAN. Emerging role of microRNA in hepatocellular carcinoma (Review). Oncology Letters 2015; 9(3): 1027 doi: 10.3892/ol.2014.2816
|
| 8 |
R. H. Xu, L. Y. Zheng, D. L. He, J. Meng, L. P. Xia, X. B. Hao, Z. Z. Zhang. RETRACTED ARTICLE: Profiling of differentially expressed microRNAs (miRNAs) during differentiation of rat hepatic oval cells (HOCs) into hepatocellular carcinoma (HCC) cells. Clinical and Translational Oncology 2015; 17(3): 230 doi: 10.1007/s12094-014-1218-2
|
| 9 |
Leila Valanejad, Kyle Lewis, Mary Wright, Yanjun Jiang, Amber D’Souza, Rebekah Karns, Rachel Sheridan, Anita Gupta, Kevin Bove, David Witte, James Geller, Gregory Tiao, David L. Nelson, Lubov Timchenko, Nikolai Timchenko. FXR-Gankyrin axis is involved in development of pediatric liver cancer. Carcinogenesis 2017; 38(7): 738 doi: 10.1093/carcin/bgx050
|
| 10 |
Wei Zhang, Kai Liu, Songyang Liu, Bai Ji, Yingchao Wang, Yahui Liu. MicroRNA-133a functions as a tumor suppressor by targeting IGF-1R in hepatocellular carcinoma. Tumor Biology 2015; 36(12): 9779 doi: 10.1007/s13277-015-3749-8
|
| 11 |
Iván Lyra-González, Laura E Flores-Fong, Ignacio González-García, David Medina-Preciado, Juan Armendáriz-Borunda. MicroRNAs dysregulation in hepatocellular carcinoma: Insights in genomic medicine. World Journal of Hepatology 2015; 7(11): 1530-1540 doi: 10.4254/wjh.v7.i11.1530
|
| 12 |
Shunzeng Lv, Bowen Sun, Congxin Dai, Ranran Shi, Xingtong Zhou, Wenyuan Lv, Xiao Zhong, Renzhi Wang, Wenbin Ma. RETRACTED ARTICLE: The Downregulation of MicroRNA-146a Modulates TGF-β Signaling Pathways Activity in Glioblastoma. Molecular Neurobiology 2015; 52(3): 1257 doi: 10.1007/s12035-014-8938-8
|
| 13 |
Qiannan Zhao, Fen Jiang, Hui Zhuang, Yanfeng Chu, Fang Zhang, Chenghong Wang. MicroRNA miR-124-3p suppresses proliferation and epithelial–mesenchymal transition of hepatocellular carcinoma via ARRDC1 (arrestin domain containing 1). Bioengineered 2022; 13(4): 8255 doi: 10.1080/21655979.2022.2051686
|
| 14 |
Enayatollah Seydi, Ahmad Salimi, Hamid Reza Rasekh, Zhaleh Mohsenifar, Jalal Pourahmad. Selective Cytotoxicity of Luteolin and Kaempferol on Cancerous Hepatocytes Obtained from Rat Model of Hepatocellular Carcinoma: Involvement of ROS-Mediated Mitochondrial Targeting. Nutrition and Cancer 2018; 70(4): 594 doi: 10.1080/01635581.2018.1460679
|
| 15 |
Qi Wang, Xiaohong Yin, Yunyi Ding, Hong Zhao, Yichen Luo. Application of biomechanics in tumor epigenetic research. Mechanobiology in Medicine 2024; 2(4): 100093 doi: 10.1016/j.mbm.2024.100093
|
| 16 |
Yoshikuni Inokawa, Kenichi Inaoka, Fuminori Sonohara, Masamichi Hayashi, Mitsuro Kanda, Shuji Nomoto. Molecular alterations in the carcinogenesis and progression of hepatocellular carcinoma: Tumor factors and background liver factors. Oncology Letters 2016; 12(5): 3662 doi: 10.3892/ol.2016.5141
|
| 17 |
Hui Quan, Bo Li, Jianjun Yang. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling. Biomedicine & Pharmacotherapy 2018; 107: 754 doi: 10.1016/j.biopha.2018.07.150
|
| 18 |
YURI TANAKA, MITSURO KANDA, HIROYUKI SUGIMOTO, DAI SHIMIZU, SATOSHI SUEOKA, HIDEKI TAKAMI, KAZUHIRO EZAKA, RYOJI HASHIMOTO, YUKIYASU OKAMURA, NAOKI IWATA, CHIE TANAKA, SUGURU YAMADA, TSUTOMU FUJII, GORO NAKAYAMA, MASAHIKO KOIKE, SHUJI NOMOTO, MICHITAKA FUJIWARA, YASUHIRO KODERA. Translational implication of Kallmann syndrome-1 gene expression in hepatocellular carcinoma. International Journal of Oncology 2015; 46(6): 2546 doi: 10.3892/ijo.2015.2965
|
| 19 |
Sahar Dehbidi, Zhaleh Farokhizadeh, Mohammad Hossein Karimi, Afsoon Afshari, Mehrdad Behmanesh, Mohammad Hossein Sanati, Bita Geramizadeh, Ramin Yaghobi. Evaluation of microRNA Gene Polymorphisms in Liver Transplant Patients with Hepatocellular Carcinoma. Hepatitis Monthly 2020; 20(7) doi: 10.5812/hepatmon.102690
|
| 20 |
Enayatollah Seydi, Shabnam Babaei, Amir Fakhri, Jalal Pourahmad. Selective toxicity of Caspian cobra ( Naja oxiana ) venom on liver cancer cell mitochondria. Asian Pacific Journal of Tropical Biomedicine 2017; 7(5): 460 doi: 10.1016/j.apjtb.2017.01.021
|
| 21 |
RYOJI HASHIMOTO, MITSURO KANDA, HIDEKI TAKAMI, DAI SHIMIZU, HISAHARU OYA, SOKI HIBINO, YUKIYASU OKAMURA, SUGURU YAMADA, TSUTOMU FUJII, GORO NAKAYAMA, HIROYUKI SUGIMOTO, MASAHIKO KOIKE, SHUJI NOMOTO, MICHITAKA FUJIWARA, YASUHIRO KODERA. Aberrant expression of melanoma-associated antigen-D2 serves as a prognostic indicator of hepatocellular carcinoma outcome following curative hepatectomy. Oncology Letters 2015; 9(3): 1201 doi: 10.3892/ol.2014.2823
|
| 22 |
Changwei Lin, Xiaorong Li, Yi Zhang, Yihang Guo, Jianyu Zhou, Kai Gao, Jing Dai, Gui Hu, Lv Lv, Juan Du, Yi Zhang. The microRNA feedback regulation of p63 in cancer progression. Oncotarget 2015; 6(11): 8434 doi: 10.18632/oncotarget.3020
|
| 23 |
Sameer A. Dhayat, Anna Hüsing, Norbert Senninger, Hartmut H. Schmidt, Jörg Haier, Heiner Wolters, Iyad Kabar, Yu-Jia Chang. Circulating microRNA-200 Family as Diagnostic Marker in Hepatocellular Carcinoma. PLOS ONE 2015; 10(10): e0140066 doi: 10.1371/journal.pone.0140066
|
| 24 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_168-1
|
| 25 |
Mitsuro Kanda, Kenta Murotani, Hiroyuki Sugimoto, Takashi Miwa, Shinichi Umeda, Masaya Suenaga, Masamichi Hayashi, Norifumi Hattori, Chie Tanaka, Daisuke Kobayashi, Suguru Yamada, Michitaka Fujiwara, Yasuhiro Kodera. An integrated multigene expression panel to predict long-term survival after curative hepatectomy in patients with hepatocellular carcinoma. Oncotarget 2017; 8(41): 71070 doi: 10.18632/oncotarget.20369
|
| 26 |
Renshun Yuan, Qiaoming Zhi, Hong Zhao, Ye Han, Ling Gao, Bin Wang, Zhongyang Kou, Zhaoji Guo, Songbing He, Xiaofeng Xue, Hao Hu. Upregulated expression of miR-106a by DNA hypomethylation plays an oncogenic role in hepatocellular carcinoma. Tumor Biology 2015; 36(4): 3093 doi: 10.1007/s13277-014-2945-2
|
| 27 |
Zeinab Ahsani, Samira Mohammadi-Yeganeh, Vahid Kia, Hamzeh Karimkhanloo, Nosratollah Zarghami, Mahdi Paryan. WNT1 Gene from WNT Signaling Pathway Is a Direct Target of miR-122 in Hepatocellular Carcinoma. Applied Biochemistry and Biotechnology 2017; 181(3): 884 doi: 10.1007/s12010-016-2256-8
|
| 28 |
Yong Gao, Juan Gu, Yueping Wang, Decai Fu, Wensheng Zhang, Guofu Zheng, Xuedong Wang. Hepatitis B virus X protein boosts hepatocellular carcinoma progression by downregulating microRNA-137. Pathology - Research and Practice 2020; 216(6): 152981 doi: 10.1016/j.prp.2020.152981
|
| 29 |
Guoliang Zhao, Chuangye Han, Zhi Zhang, Lei Wang, Jing Xu. Increased expression of microRNA-31-5p inhibits cell proliferation, migration, and invasion via regulating Sp1 transcription factor in HepG2 hepatocellular carcinoma cell line. Biochemical and Biophysical Research Communications 2017; 490(2): 371 doi: 10.1016/j.bbrc.2017.06.050
|
| 30 |
Hao Zheng, Yuan Yang, Meng-chao Wang, Sheng-xian Yuan, Tao Tian, Jun Han, Jun-sheng Ni, Jian Wang, Hao Xing, Wei-ping Zhou. Low CDX1 expression predicts a poor prognosis for hepatocellular carcinoma patients after hepatectomy. Surgical Oncology 2016; 25(3): 171 doi: 10.1016/j.suronc.2016.05.026
|
| 31 |
Grazia Maria Virzì, Anna Clementi, Alessandra Brocca, Claudio Ronco. Endotoxin Effects on Cardiac and Renal Functions and Cardiorenal Syndromes. Blood Purification 2017; 44(4): 314 doi: 10.1159/000480424
|
| 32 |
Matthew M Yeh, Raymond S Yeung, Smith Apisarnthanarax, Renuka Bhattacharya, Carlos Cuevas, William P Harris, Tony Lim Kiat Hon, Siddharth A Padia, James O Park, Kevin M Riggle, Sayed S Daoud. Multidisciplinary perspective of hepatocellular carcinoma: A Pacific Northwest experience. World Journal of Hepatology 2015; 7(11): 1460-1483 doi: 10.4254/wjh.v7.i11.1460
|
| 33 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_175-1
|
| 34 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 3029 doi: 10.1007/978-3-319-26956-6_168
|
| 35 |
Hamzeh Karimkhanloo, Samira Mohammadi-Yeganeh, Zeinab Ahsani, Mahdi Paryan. Bioinformatics prediction and experimental validation of microRNA-20a targeting Cyclin D1 in hepatocellular carcinoma. Tumor Biology 2017; 39(4): 101042831769836 doi: 10.1177/1010428317698361
|
| 36 |
Grazia Maria Virzì, Anna Clementi, Giovanni Giorgio Battaglia, Claudio Ronco. Multi-Omics Approach: New Potential Key Mechanisms Implicated in Cardiorenal Syndromes. Cardiorenal Medicine 2019; 9(4): 201 doi: 10.1159/000497748
|
| 37 |
Zhenpeng Qiu, Junxuan Zhou, Cong Zhang, Ye Cheng, Junjie Hu, Guohua Zheng. Antiproliferative effect of urolithin A, the ellagic acid-derived colonic metabolite, on hepatocellular carcinoma HepG2.2.15 cells by targeting Lin28a/let-7a axis. Brazilian Journal of Medical and Biological Research 2018; 51(7) doi: 10.1590/1414-431x20187220
|
| 38 |
Feng Wang, Houqun Ying, Bangshun He, Yuqin Pan, Huiling Sun, Shukui Wang. Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma. Tumor Biology 2016; 37(4): 4945 doi: 10.1007/s13277-015-4340-z
|
| 39 |
Ting Peng, Yujiao He, Tao Wang, Jialing Yu, Xiaofang Ma, Zongyuan Zhou, Yuwen Sheng, Lingyu Li, Huipan Peng, Sheng Li, Jiawei Zou, Yi Yuan, Yongyun Zhao, Hailong Shi, Fu Li, Wanli Liu, Kaifeng Hu, Xiaoxia Lu, Guolin Zhang, Fei Wang. Discovery of a Novel Small-Molecule Inhibitor Disrupting TRBP–Dicer Interaction against Hepatocellular Carcinoma via the Modulation of microRNA Biogenesis. Journal of Medicinal Chemistry 2022; 65(16): 11010 doi: 10.1021/acs.jmedchem.2c00189
|
| 40 |
DAI SHIMIZU, MITSURO KANDA, HIROYUKI SUGIMOTO, SATOSHI SUEOKA, HIDEKI TAKAMI, KAZUHIRO EZAKA, YURI TANAKA, RYOJI HASHIMOTO, YUKIYASU OKAMURA, NAOKI IWATA, CHIE TANAKA, SUGURU YAMADA, TSUTOMU FUJII, GORO NAKAYAMA, MASAHIKO KOIKE, SHUJI NOMOTO, MICHITAKA FUJIWARA, YASUHIRO KODERA. NRAGE promotes the malignant phenotype of hepatocellular carcinoma. Oncology Letters 2016; 11(3): 1847 doi: 10.3892/ol.2016.4120
|
| 41 |
Guangbin Jiang, Li Wen, Weiping Deng, Zhiyuan Jian, Hongmei Zheng. Regulatory role of miR-211-5p in hepatocellular carcinoma metastasis by targeting ZEB2. Biomedicine & Pharmacotherapy 2017; 90: 806 doi: 10.1016/j.biopha.2017.03.081
|
| 42 |
Hisaharu Oya, Mitsuro Kanda, Hiroyuki Sugimoto, Dai Shimizu, Hideki Takami, Soki Hibino, Ryoji Hashimoto, Yukiyasu Okamura, Suguru Yamada, Tsutomu Fujii, Goro Nakayama, Masahiko Koike, Shuji Nomoto, Michitaka Fujiwara, Yasuhiro Kodera. Dihydropyrimidinase-like 3 is a putative hepatocellular carcinoma tumor suppressor. Journal of Gastroenterology 2015; 50(5): 590 doi: 10.1007/s00535-014-0993-4
|
| 43 |
Xingxue Yan, Zhendong Zhu, Shenmin Xu, Li-nan Yang, Xin-Hua Liao, Min Zheng, Dayun Yang, Jichuang Wang, Dongmei Chen, Long Wang, Xiaolong Liu, Jingfeng Liu, Ruey-Hwa Chen, Xiao Zhen Zhou, Kun Ping Lu, Hekun Liu. MicroRNA-140-5p inhibits hepatocellular carcinoma by directly targeting the unique isomerase Pin1 to block multiple cancer-driving pathways. Scientific Reports 2017; 7(1) doi: 10.1038/srep45915
|
| 44 |
Grazia Maria Virzì, Anna Clementi, Alessandra Brocca, Massimo de Cal, Claudio Ronco. Molecular and Genetic Mechanisms Involved in the Pathogenesis of Cardiorenal Cross Talk. Pathobiology 2016; 83(4): 201 doi: 10.1159/000444502
|
| 45 |
Xi-Dai Long, Wei-Zhong Tang, Jun Lu, Xiao-Ying Huang, Jin-Guang Yao, Tian-Qi Zhang, Xing-Zhizi Wang, Qun-Ying Su, Chun-Ying Luo, Xue-Ming Wu, Chao Wang, Li-Xia Zeng, Qiang Xia, Yun Ma. Hepatocellular Carcinoma - Advances in Diagnosis and Treatment. 2018; doi: 10.5772/intechopen.72276
|
| 46 |
Hongxia Fu, Jicai Zhang, Tongshan Pan, Shuying Ai, Li Tang, Fengqin Wang. miR‑378a enhances the sensitivity of liver cancer to sorafenib by targeting VEGFR, PDGFRβ and c‑Raf. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.8390
|
| 47 |
Zhi-yu Wang, Wei Zhang, Jin-jian Yang, Dong-kui Song, Jin-xing Wei. Expression of miRNA-630 in bladder urothelial carcinoma and its clinical significance. Journal of Huazhong University of Science and Technology [Medical Sciences] 2016; 36(5): 705 doi: 10.1007/s11596-016-1648-x
|
| 48 |
Mitsuro Kanda, Hiroyuki Sugimoto, Yasuhiro Kodera. Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(37): 10584-10597 doi: 10.3748/wjg.v21.i37.10584
|
| 49 |
SHU-LIANG ZHANG, LING LIU. microRNA-148a inhibits hepatocellular carcinoma cell invasion by targeting sphingosine-1-phosphate receptor 1. Experimental and Therapeutic Medicine 2015; 9(2): 579 doi: 10.3892/etm.2014.2137
|
| 50 |
Xiangjun Sun, Yonglei Liu, Ming Li, Mingchun Wang, Yutong Wang. Involvement of miR-485-5p in hepatocellular carcinoma progression targeting EMMPRIN. Biomedicine & Pharmacotherapy 2015; 72: 58 doi: 10.1016/j.biopha.2015.04.008
|
| 51 |
Guang-Ping Qiu, Jie Liu. MicroRNA Gene Polymorphisms in Evaluating Therapeutic Efficacy After Transcatheter Arterial Chemoembolization for Primary Hepatocellular Carcinoma. Genetic Testing and Molecular Biomarkers 2016; 20(10): 579 doi: 10.1089/gtmb.2016.0073
|
| 52 |
Jiangang Bi, Yusheng Guo, Qi Li, Liping Liu, Shiyun Bao, Ping Xu, Olorunseun Ogunwobi. Role of long intergenic non-protein coding RNA 01857 in hepatocellular carcinoma malignancy via the regulation of the microRNA-197-3p/anterior GRadient 2 axis. PLOS ONE 2021; 16(11): e0258312 doi: 10.1371/journal.pone.0258312
|
| 53 |
Grazia Maria Virzì, Anna Clementi. Textbook of Cardiorenal Medicine. 2021; : 165 doi: 10.1007/978-3-030-57460-4_14
|
| 54 |
Hong‐Cheng Lv, Yan‐Yan Lv, Gang Wang, Xie‐Hua Zhang, Sheng‐Nan Li, Xiao‐Fen Yue, Wei Lu. Mechanism of miR‐424‐5p promoter methylation in promoting epithelial–mesenchymal transition of hepatocellular carcinoma cells. The Kaohsiung Journal of Medical Sciences 2022; 38(4): 336 doi: 10.1002/kjm2.12499
|
| 55 |
Hamzeh Karimkhanloo, Samira Mohammadi-Yeganeh, Razie Hadavi, Ameneh Koochaki, Mahdi Paryan. Potential role of miR-214 in β-catenin gene expression within hepatocellular carcinoma. Molecular Biology Reports 2020; 47(10): 7429 doi: 10.1007/s11033-020-05798-5
|
| 56 |
Sharad Khare, Tripti Khare, Raghu Ramanathan, Jamal A. Ibdah. Hepatocellular Carcinoma: The Role of MicroRNAs. Biomolecules 2022; 12(5): 645 doi: 10.3390/biom12050645
|
| 57 |
Gamalat El Gedawy, Manar Obada, Ayman Kelani, Hala El-Said, Naglaa M. Ghanayem. Circulating MiRNA-21 and programed cell death (PDCD) 4 gene expression in hepatocellular carcinoma (HCC) in Egyptian patients. Egyptian Journal of Medical Human Genetics 2017; 18(2): 137 doi: 10.1016/j.ejmhg.2016.04.007
|
| 58 |
Ning Liu, Fan Jiang, Tian-Lin He, Jun-Kuan Zhang, Juan Zhao, Chun Wang, Gui-Xing Jiang, Li-Ping Cao, Peng-Cheng Kang, Xiang-Yu Zhong, Tian-Yu Lin, Yun-Fu Cui. The Roles of MicroRNA-122 Overexpression in Inhibiting Proliferation and Invasion and Stimulating Apoptosis of Human Cholangiocarcinoma Cells. Scientific Reports 2015; 5(1) doi: 10.1038/srep16566
|
| 59 |
Noushin Nabavi, Nur Ridzwan Nur Saidy, Erik Venalainen, Anne Haegert, Abhijit Parolia, Hui Xue, Yuwei Wang, Rebecca Wu, Xin Dong, Colin Collins, Francesco Crea, Yuzhuo Wang.
miR-100-5p inhibition induces apoptosis in dormant prostate cancer cells and prevents the emergence of castration-resistant prostate cancer. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-03731-8
|
| 60 |
Grazia Maria Virzì, Anna Clementi, Alessandra Brocca, Massimo de Cal, Claudio Ronco. Epigenetics: a potential key mechanism involved in the pathogenesis of cardiorenal syndromes. Journal of Nephrology 2018; 31(3): 333 doi: 10.1007/s40620-017-0425-7
|
| 61 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 3203 doi: 10.1007/978-3-319-26956-6_175
|
| 62 |
MITSURO KANDA, HIROYUKI SUGIMOTO, SHUJI NOMOTO, HISAHARU OYA, SOKI HIBINO, DAI SHIMIZU, HIDEKI TAKAMI, RYOJI HASHIMOTO, YUKIYASU OKAMURA, SUGURU YAMADA, TSUTOMU FUJII, GORO NAKAYAMA, MASAHIKO KOIKE, MICHITAKA FUJIWARA, YASUHIRO KODERA. B-cell translocation gene 1 serves as a novel prognostic indicator of hepatocellular carcinoma. International Journal of Oncology 2015; 46(2): 641 doi: 10.3892/ijo.2014.2762
|